Phase 1/2, Open-label, Multicenter, First-in-Human Study of DS-3939a in Subjects With Advanced Solid Tumors

Condition: Breast Cancer, Non-small Cell Lung Cancer, Urothelial Carcinoma


Go To Trial Homepage